2020亚太药物研发领袖峰会-细胞与基因治疗研发及生产工艺技术论坛

行业领域： 药物研发、细胞与基因治疗、生物制药

会议类型： 峰会、论坛、技术研讨会

会议主题： 聚焦细胞与基因治疗研发及生产工艺技术，探讨全球视野、技术创新与产业发展

• 开始时间： 2020年10月15日 08:00:00
• 结束时间： 2020年10月16日 18:00:00
• 会议地点： 上海锦江汤臣洲际大酒店
• 组织机构： 迪易咨询, Deliver, Life, Sciences
• 联系信息：
  • 联系人：[此处填写联系人姓名]
  • 邮件地址：[此处填写邮件地址]
  • 联系电话：[此处填写联系电话]
  • 联系传真：[此处填写联系传真]
• 会议日程： [最终日程以会议现场为准]
• Confirmed Speakers & Hot Topics：
  • Stephan Grupp教授：The CAR-T PIONEER PLENARY KEYNOTE SPEECH
  • Travis Young教授：Controllable CAR-T Cell Therapy
  • Xiu-Yan Wang博士：The State of the ART of Manufacturing CAR T Cells and The Latest Advancements
  • Steve Oh教授：A Broad Technology Platform for Reprogramming, Expansion of Pluripotent Stem Cells and Differentiation to Cell & Gene Therapies
  • Yoji Sato教授：Regulations and Platforms for Ensuring the Quality, Safety and Efficacy of Cell Therapy Products in Japan
  • Sergio Fracchia博士：The Kymriah Story: Challenges, Headaches and Solutions on Manufacturing and Quality Control
  • Wen Bo Wang博士：Developing Allogeneic Cancer Immunotherapy with iPSC Technology
  • Yajin (Jenny) Ni博士：Cell Therapy Bioprocessing and Allogeneic Manufacturing Solutions for Cell Therapy Products
  • Harry Lam博士：Cell Therapy Manufacturing Commercialization -- Strategy and Challenges
  • 王立群博士：Revolution of CAR-T Cell Therapies – Regulatory and Commercialization Considerations for Yescarta in China
  • 张宇博士：The Aeon experience of translating and developing a FIC&FIH CAR-T product in China
  • 刘必佐先生：CBMG Commercialization Strategies for Cell and Gene Therapies; Particularly in China
  • 杨林博士：Automated Manufacturing of Chimeric Antigen Receptor T Cells
  • 其他演讲嘉宾：[此处填写其他演讲嘉宾信息]
• 小组讨论： Establishing a Robust, Scalable, Automated, Functionally-closed Manufacturing Process to Support a Pipeline of Emerging CAR-T Cell Immunotherapy
• 圆桌讨论： Global CAR-T Pioneers Fireside Chat: Revolution and Strengthening Academia-Industry Collaboration for Development Next Generation CAR T-Cell Therapies
• 参展指南：
  • For Pharma/Biotech：CNY 4,800
  • For Service/Solution Providers：CNY 6,800